SpineOvations, a medical technology company, develops and commercializes products for the diagnosis and treatment of spinal disorders. It focuses on the development of novel, biocompatible injectables for the stabilization of spinal disc integrity; and for other orthopedic applications that include non-surgical connective tissue repair. Its technology platform consists of a novel non-surgical application for identifying and treating spinal discs that have tears or fissures in order to seal the defect and enhance structural integrity.
SpineOvations offers DiscSeal, a percutaneous injection treatment for patients with internal disc derangement and suffering from chronic discogenic lower back pain. Its DiscSeal product is designed to be an early-stage treatment for those patients who have failed conservative care and who are not yet candidates for the invasive surgical treatment options of total disc replacement or spinal fusion.
SpineOvations was founded in 2004. It has its headquarters in San Diego in California.